The drops are said to treat eye allergies and inflammation, making the new FDA warning particularly timely.

Eye drops recalled: A California-based firm has voluntarily recalled more than 3.1 million bottles of eye drops distributed under various store-brand labels across the United States. The recall was ...

OCS-01 failed to meet the primary endpoint of improving visual acuity in both Phase 3 DIAMOND studies. ・The treatment reduced retinal thickness versus placebo, but those benefits did not translate ...

A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – and thus could not prove – whether the products were sterile. These ...

Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary ...

More than 3 million bottles of eye drops have been recalled over concerns they may not be sterile, according to an enforcement report from the U.S. Food and Drug Administration. Product distributor ...